- Home
- SITC vs ABCL Comparison
SITC vs ABCL Comparison
Compare SITC & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SITC
- ABCL
- Stock Information
- Founded
- SITC 1965
- ABCL 2012
- Country
- SITC United States
- ABCL Canada
- Employees
- SITC N/A
- ABCL N/A
- Industry
- SITC Real Estate Investment Trusts
- ABCL Biotechnology: Pharmaceutical Preparations
- Sector
- SITC Real Estate
- ABCL Health Care
- Exchange
- SITC Nasdaq
- ABCL Nasdaq
- Market Cap
- SITC 786.5M
- ABCL 818.2M
- IPO Year
- SITC 1993
- ABCL 2020
- Fundamental
- Price
- SITC $14.89
- ABCL $3.21
- Analyst Decision
- SITC Hold
- ABCL Buy
- Analyst Count
- SITC 9
- ABCL 3
- Target Price
- SITC $38.78
- ABCL $8.00
- AVG Volume (30 Days)
- SITC 776.1K
- ABCL 4.0M
- Earning Date
- SITC 02-11-2025
- ABCL 02-27-2025
- Dividend Yield
- SITC 6.98%
- ABCL N/A
- EPS Growth
- SITC 757.51
- ABCL N/A
- EPS
- SITC 13.71
- ABCL N/A
- Revenue
- SITC $451,683,000.00
- ABCL $32,962,000.00
- Revenue This Year
- SITC N/A
- ABCL N/A
- Revenue Next Year
- SITC N/A
- ABCL $37.26
- P/E Ratio
- SITC $1.09
- ABCL N/A
- Revenue Growth
- SITC N/A
- ABCL N/A
- 52 Week Low
- SITC $14.55
- ABCL $2.34
- 52 Week High
- SITC $64.44
- ABCL $5.46
- Technical
- Relative Strength Index (RSI)
- SITC 43.22
- ABCL 53.16
- Support Level
- SITC $14.55
- ABCL $2.96
- Resistance Level
- SITC $15.44
- ABCL $3.32
- Average True Range (ATR)
- SITC 0.38
- ABCL 0.21
- MACD
- SITC -0.01
- ABCL -0.02
- Stochastic Oscillator
- SITC 24.28
- ABCL 45.98
About SITC SITE Centers Corp.
SITE Centers Corp is a United States-based self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing and managing shopping centers.
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.